Back

Age-predicted maximal heart rate reserve as an alternative prognostic parameter in patients with heart failure with preserved ejection fraction -insights from PURSUIT-HFpEF registry-

1 September 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: HFpEF: data from animal studies and registries Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masato Okada

Sakurabashi-Watanabe Hospital, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction
Doctor L. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Role of the alarmin S100A9 in the pathogenesis of heart failure with preserved ejection fraction
Ms I. Voss (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Characterization and progression of heart failure with preserved ejection fraction in SDT fatty rats.
Doctor R. Assaly (Escalquens, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of left atrial reverse remodeling in patients with ADHF-HFpEF regardless of atrial fibrillation -PURSUIT-HFpEF Registry-
Doctor T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Gender differences in the evolution of echocardiographic HFpEF characteristics through age deciles: is menopause an inflection point?
Doctor K. George (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF: data from animal studies and registries

The Event

Event poster

ESC Congress 2024

1 September 2024 07:55 CET
You may be interested in
thumbnail
Congress Session
Delving deeper into HFpEF
thumbnail
Congress Presentation
Prognostic value of peak heart rate on cardiopulmonary exercise testing in patients with chronic heart failure
thumbnail
Congress Presentation
Machine learning for development of ECG-based prediction models for atrial fibrillation, thromboembolism and mortality in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources